Home » CHIESI GROUP LAUNCH NEW PRODUCT INTO UK £80 MILLION ASTHMA MARKET
CHIESI GROUP LAUNCH NEW PRODUCT INTO UK £80 MILLION ASTHMA MARKET
Chiesi Group announces the UK launch of Clenil Modulite (beclometasone dipropionate [BDP), a new CFC-free metered-dose inhaler (MDI) by their UK affiliate Trinity-Chiesi Pharmaceuticals. There are several CFC-free reliever inhalers currently available
in the UK but Clenil Modulite is only the second CFC-free preventer (BDP) inhaler
in this market.
PR
Web
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May